Consolidated Balance Sheets - USD ($) $ in Millions		Dec. 31, 2016		Dec. 31, 2015
Current Assets
Cash and cash equivalents (variable interest entities restricted - 2016: $75; 2015: $158)		$ 6,607		$ 8,577
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2016: $110; 2015: $94)		4,666		4,078
Other		4,358		3,768
Inventories		7,363		6,871
Other current assets		665		647
Total current assets		23,659		23,941
Investments
Investment in nonconsolidated affiliates		3,747	[1]	3,958
Other investments (investments carried at fair value - 2016: $1,959; 2015: $1,866)		2,969		2,923
Noncurrent receivables		708		816
Total investments		7,424		7,697
Property
Property		57,438		50,802
Less accumulated depreciation		33,952		32,948
Net property (variable interest entities restricted - 2016: $961; 2015: $1,717)		23,486		17,854
Other Assets
Goodwill		15,272		12,154
Other intangible assets (net of accumulated amortization - 2016: $4,295; 2015: $3,770)		6,026		3,617
Deferred income tax assets		3,079		2,140
Deferred charges and other assets		565		535
Total other assets		24,942		18,446
Total Assets	[2]	79,511	[1]	67,938
Current Liabilities
Notes payable		272		454
Long-term debt due within one year	[3]	635		541
Accounts payable:
Trade		4,519		3,577
Other		2,401		2,287
Income taxes payable		600		452
Dividends payable		508		592
Accrued and other current liabilities		3,669		3,212
Total current liabilities		12,604		11,115
Long-Term Debt (variable interest entities nonrecourse - 2016: $330; 2015: $487)		20,456		16,215
Other Noncurrent Liabilities
Deferred income tax liabilities		923		587
Pension and other postretirement benefits - noncurrent		11,375		9,119
Asbestos-related liabilities - noncurrent		1,364		387
Other noncurrent obligations		5,560		4,332
Total other noncurrent liabilities		19,222		14,425
Stockholders' Equity
Preferred stock, series A (issued $1.00 par, $1,000 liquidation preference; outstanding 2016: zero; 2015: 4,000,000 shares)		0		4,000
Common stock (authorized 1,500,000,000 shares of $2.50 par value each; issued 2016: 1,242,794,836 shares; 2015: 1,242,794,836 shares)		3,107		3,107
Additional paid-in capital		4,262		4,936
Retained earnings		30,338		28,425
Accumulated other comprehensive loss		(9,822)		(8,667)
Unearned ESOP shares		(239)		(272)
Treasury stock at cost (2016: 31,661,501 shares; 2015: 125,853,161 shares)		(1,659)		(6,155)
The Dow Chemical Company's stockholders' equity		25,987		25,374
Noncontrolling interests		1,242		809
Total equity		27,229		26,183
Total Liabilities and Equity		$ 79,511		$ 67,938

[1] Equity contributions to Sadara, which prior to 2016 were reflected in the Corporate segment, were reallocated to Performance Materials & Chemicals and Performance Plastics in 2016.

[2] Presented in accordance with newly implemented ASU 2015-17 and ASU 2015-03. See Notes 1 and 2 for additional information.

[3] Presented net of current portion of unamortized debt issuance costs of $24 million at December 31, 2016 and $9 million at December 31, 2015.